WINT (Windtree Therapeutics, Inc.) מקדם שווי פעילות להכנסות

Windtree Therapeutics Inc. (WINT) - לוגו תאגידי

Windtree Therapeutics (WINT) develops drugs in the US to stabilize patients with acute heart failure. The change in the EV/Sales valuation on the GURU.Markets service confirms the asset's dynamics, where becomes the new value of the indicator. The business relies on a sovereign cycle independent of macroeconomics, while a team of top-tier cardiologists is retained through test autonomy and clinical options.

Windtree - מכפיל EV/Sales WINT (תקופה 04.07.2022 - 20.11.2026)

Windtree Therapeutics - פילוחים אנליטיים ומדדי מפתח (WINT)

- מדדי הערכת שווי שוק של העסק:
ניתוח ראשוני של החברה:Windtree Therapeutics Inc.
דוגמת מוצר של Windtree

For Windtree Therapeutics (WINT), an innovator in acute heart failure therapy, this indicator links the business's market value to its sales volume. By analyzing the enterprise value-to-revenue ratio, an investor assesses the total enterprise value (EV) relative to operating income, which offsets the impact of debt load and determines the company's fundamental stability within the hospital cardiology segment.